125 related articles for article (PubMed ID: 29432024)
41. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
[TBL] [Abstract][Full Text] [Related]
42. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
Gan CZ; Li G; Luo QS; Li HM
IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
[TBL] [Abstract][Full Text] [Related]
43. Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer.
Dai X; Fan W; Wang Y; Huang L; Jiang Y; Shi L; Mckinley D; Tan W; Tan C
Mol Pharm; 2016 Feb; 13(2):520-33. PubMed ID: 26636714
[TBL] [Abstract][Full Text] [Related]
44. MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3.
Li Y; Cai B; Shen L; Dong Y; Lu Q; Sun S; Liu S; Ma S; Ma PX; Chen J
Cancer Lett; 2017 Jul; 397():111-119. PubMed ID: 28365400
[TBL] [Abstract][Full Text] [Related]
45. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
[TBL] [Abstract][Full Text] [Related]
46. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
47. Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer-let-7i chimera.
Liu N; Zhou C; Zhao J; Chen Y
Cancer Invest; 2012 Oct; 30(8):577-82. PubMed ID: 22812695
[TBL] [Abstract][Full Text] [Related]
48. One-Step Self-Assembly of Multifunctional DNA Nanohydrogels: An Enhanced and Harmless Strategy for Guiding Combined Antitumor Therapy.
Wei H; Zhao Z; Wang Y; Zou J; Lin Q; Duan Y
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46479-46489. PubMed ID: 31747745
[TBL] [Abstract][Full Text] [Related]
49. Ultrasensitive cytosensing based on an aptamer modified nanobiosensor with a bioconjugate: Detection of human non-small-cell lung cancer cells.
Mir TA; Yoon JH; Gurudatt NG; Won MS; Shim YB
Biosens Bioelectron; 2015 Dec; 74():594-600. PubMed ID: 26190471
[TBL] [Abstract][Full Text] [Related]
50. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of Thermal Damage to Adenocarcinoma Cells by Iron Nanoparticles Modified with MUC1 Aptamer.
Guo F; Hu Y; Yu L; Deng X; Meng J; Wang C; Yang XD
J Nanosci Nanotechnol; 2016 Mar; 16(3):2246-53. PubMed ID: 27455625
[TBL] [Abstract][Full Text] [Related]
52. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.
Moro M; Di Paolo D; Milione M; Centonze G; Bornaghi V; Borzi C; Gandellini P; Perri P; Pastorino U; Ponzoni M; Sozzi G; Fortunato O
J Control Release; 2019 Aug; 308():44-56. PubMed ID: 31299263
[TBL] [Abstract][Full Text] [Related]
53. Anti-MUC1 Aptamer/Negatively Charged Amino Acid Dendrimer Conjugates for Targeted Delivery to Human Lung Adenocarcinoma A549 Cells.
Masuda M; Kawakami S; Wijagkanalan W; Suga T; Fuchigami Y; Yamashita F; Hashida M
Biol Pharm Bull; 2016; 39(10):1734-1738. PubMed ID: 27725454
[TBL] [Abstract][Full Text] [Related]
54. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract][Full Text] [Related]
55. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
Han Y; Zhang P; Chen Y; Sun J; Kong F
Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
[TBL] [Abstract][Full Text] [Related]
56. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles.
Varnamkhasti BS; Hosseinzadeh H; Azhdarzadeh M; Vafaei SY; Esfandyari-Manesh M; Mirzaie ZH; Amini M; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2015 Oct; 494(1):430-44. PubMed ID: 26315125
[TBL] [Abstract][Full Text] [Related]
57. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
58. 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.
Moosavian SA; Abnous K; Akhtari J; Arabi L; Gholamzade Dewin A; Jafari M
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2054-2065. PubMed ID: 29205059
[TBL] [Abstract][Full Text] [Related]
59. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells.
Yan MD; Yao CJ; Chow JM; Chang CL; Hwang PA; Chuang SE; Whang-Peng J; Lai GM
Mar Drugs; 2015 Sep; 13(10):6099-116. PubMed ID: 26404322
[TBL] [Abstract][Full Text] [Related]
60. Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer.
Ma W; Ma CN; Li XD; Zhang YJ
Cancer Gene Ther; 2016; 23(2-3):66-71. PubMed ID: 26915403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]